38714 Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices 

CONTACT PERSON FOR MORE INFORMATION: 

Judith Ingram, Press Officer. Telephone: 

(202) 694–1220. 

Vicktoria J. Allen, 

Acting Deputy Secretary of the Commission. 

[FR Doc. 2021–15734 Filed 7–20–21; 4:15 pm] 

BILLING CODE 6715–01–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (Act) (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

applications are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than August 6, 2021. 

A. Federal Reserve Bank of Dallas 

(Karen Smith, Director, Applications) 

2200 North Pearl Street, Dallas, Texas 

75201–2272: 

1. The Vanguard Group, Inc., 

Malvern, Pennsylvania; on behalf of 

itself, its subsidiaries and affiliates, 

including investment companies 

registered under the Investment 

Company Act of 1940, other pooled 

investment vehicles, and institutional 

accounts that are sponsored, managed, 

or advised by Vanguard; to acquire 

additional voting shares of Comerica 

Incorporated, Dallas, Texas, and thereby 

indirectly acquire additional voting 

shares of Comerica Bank, Dallas, Texas, 

and Comerica Bank & Trust, National 

Association, Ann Arbor, Michigan. 

Board of Governors of the Federal Reserve 

System, July 19, 2021. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2021–15593 Filed 7–21–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

information collection project: ‘‘The 

AHRQ Safety Program for MethicillinResistant Staphylococcus aureus 

(MRSA) Prevention.’’ This proposed 

information collection was previously 

published in the Federal Register on 

May 3rd, 2021 and allowed 60 days for 

public comment. AHRQ did not receive 

any substantive comments from 

members of the public. The purpose of 

this notice is to allow an additional 30 

days for public comment. 

DATES: Comments on this notice must be 

received by August 23, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain . Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

The AHRQ Safety Program for 

Methicillin-Resistant Staphylococcus 

aureus (MRSA) Prevention 

As part of the HHS HAI National 

Action Plan (NAP), AHRQ has 

supported the implementation and 

adoption of the Comprehensive Unitbased Safety Program (CUSP) to reduce 

Central-Line Associated Bloodstream 

Infections (CLABSI) and CatheterAssociated Urinary Tract Infections 

(CAUTI), and subsequently applied 

CUSP to other clinical challenges, 

including reducing surgical site 

infections and improving care for 

mechanically ventilated patients. As 

part of the National Action Plan for 

Combating Antibiotic-Resistant Bacteria 

(CARB NAP), the HHS HAI National 

Action Plan, and Healthy People 2030 

goals, AHRQ will now apply the 

principles and concepts that have been 

learned from these HAI reduction efforts 

to the prevention of MRSA invasive 

infections. 

Healthcare-associated infections, or 

HAIs, are a highly significant cause of 

illness and death for patients in the U.S. 

At any given time, HAIs affect one out 

of every 31 hospital inpatients. More 

than a million of these infections occur 

across our health care system every 

year. This leads to significant patient 

harm and loss of life, and costs billions 

of dollars each year in medical and nonmedical costs. In addition, the 3 million 

Americans currently residing in U.S. 

nursing homes experience a staggering 

2–3 million HAIs each year. 

Particular concern has arisen related 

to the persistent prevalence of 

methicillin-resistant Staphylococcus 

aureus (MRSA). This bacterium affects 

both communities and healthcare 

facilities, but the majority of morbidity 

and mortality occurs in critically and 

chronically ill patients. While MRSA 

was rare in the US through the 1970s, 

its prevalence in US health care 

facilities began rising in the 1980s and 

has continued to do so. In 2000, MRSA 

was responsible for 133,510 

hospitalizations in children and adults. 

This number more than doubled by 

2005, with 278,203 hospitalizations 

along with 56,248 septic events and 

6,639 deaths being attributed to MRSA. 

MRSA has become a major form of 

hospital-associated Staphylococcus 

aureus infection. 

For various patient safety initiatives, 

AHRQ has promoted the 

implementation and adoption of the 

Comprehensive Unit-based Safety 

Program (CUSP) approach which 

combines clinical and cultural (i.e., 

technical and adaptive) intervention 

components to facilitate the 

implementation of technical bundles to 

improve patient safety. For MRSA 

prevention, it is likely that a 

combination of technical approaches is 

indicated, including decolonization 

along with classic infection control 

practices such as hand hygiene, 

environmental cleaning, general HAI 

prevention, and contact precautions/ 

isolation. Implementation of these 

technical approaches would benefit 


lotter on DSK11XQN23PROD with NOTICES1